Table 2.

Genetic Alterations Significantly Associated with Metastatic sites.

Mutaion	None (n = 41)	Liver (n = 45)	Other Sites (n = 30)	p-Value
BRCA2 mutation				0.0162
No	41	40	30
Point mutation	0	5	0